Gr. Sarantis S.a. · ATHEX:SAR
Gr. Sarantis — Sarantis Group — H1 2024 Earnings Presentation
37 slides from Gr. Sarantis's earnings presentation, 2024
Slide 1: Sarantis Group Investors Presentation
Sarantis Group Investors Presentation
Slide 2: Forward-looking statement
Forward-looking statement This document contains certain “forward-looking” statements. These statements are based on management’s current expectations and are naturally subject to uncertainty and changes in circumstances, which could affect materially the expected results, because current expectatio
Slide 3: With you today
With you today Giannis Bouras Christos Varsos Group Chief Executive Officer Group Chief Financial Officer 3 Sarantis Group Investors Presentation
Slide 4: Setting the base for sustainable organic growth
Setting the base for sustainable organic growth Giannis Bouras, Group CEO
Slide 5: A long history of 60 years
A long history of 60 years 2015 Milestone acquisitions: 1964 Establishment of 1994 New production facilities Polipak, Ergopack, Stella GR. SARANTIS S.A. 2000 in Athens 2024 Pack Expansion in Eastern Investments in Europe infrastructure New exclusive strategic agreements Intense Acquisition Listed on
Slide 6: We care for the future the same way we care about the present
We care for the future the same way we care about the present OUR COMPETITIVE ADVANTAGE OUR SCOPE ▪ We design for the CEE region with deep local consumer understanding ▪ CEE and selected international markets on beauty ▪ We are the revitalisers of local “jewel” brands ▪ Home Care solutions ▪ We inve
Slide 7: Consistent organic growth with acquisitions coming on top
Consistent organic growth with acquisitions coming on top Sarantis Group Growth Drivers Beauty & Skin Personal Home Care Strategic Care Care Solutions Partnerships Disproportionate Core Profit Significant growth driver Market leverage growth Generator Complementary acquisitions on top in key priorit
Slide 8: Simplification and efficiency – progress
Simplification and efficiency – progress Main projects on track ▪ New SAP implementation – Accelerating Design phase completed ▪ On track for Go-live digital ▪ Integrated Business Planning transformation Process – On track for Go-live Steadily focused on ▪ Portfolio Optimisation - including Stella P
Slide 9: We continue investing in the enhancement of our footprint
We continue investing in the enhancement of our footprint Sustainable development Investments Installation of a new Doypack Investment in production unit in Oinofyta regranulation (Greece) production plant and processes in Polipak’s launch of the new Noxzema plant Shower Gel and Liquid Cream Soaps D
Slide 10: Well-placed for Sustainable Growth
Well-placed for 10 Sustainable Growth Net Sales €740m Net Sales €660m EBITDA €100m 2X EBITDA to €120m Net Sales €482.2m EBITDA €61.6m EBIT 77€m 2X EBIT to 95€m Net Sales €445.1m EBIT €47.1m EBITDA €45.5m from 2023 EBIT €32.2m 2022 2023 2026 2028 www.companyname.com © 2016 Startup theme. All Rights R
Slide 11: Financial Performance
Financial Performance Delivering strong performance Christos Varsos, Group Chief Financial Officer
Slide 12: Strong growth momentum and solid performance for 9M 2024
Strong growth momentum and solid performance for 9M 2024 9M 24 Reported Net Sales 9M 24 Comparable Net Sales (including Stella Pack) (excluding Stella Pack) € 452.0m € 393.3m + 27.9% + 11.3% Reported EBITDA Comparable EBITDA Robust Financial Position € 63.0m € 54.7m Net Debt €12.4m + 31.7% + 14.3% a
Slide 13: Focused execution drives strong performance reaffirming robust organic growth
Focused execution drives strong performance reaffirming the robust organic growth mechanism Consolidated Statement of Comprehensive income Reported Figures (including Stella Pack) Comparable Figures (excluding Stella Pack*) Amounts In €m H1 2024 H1 2023 Δ H1 2024 H1 2023 Δ% (unless otherwise stated)
Slide 14: Building further on our home care strength
Building further on our home care strength Acquisition completed in January 2024 Integration on track Focus on supply chain unification H1 2024 (€m) Further investments in regranulation to support the full portfolio Net Sales 39.2 Gross Profit 11.0 Gross Profit margin 27.9% EBIT 3.6 EBIT margin 9.2%
Slide 15: Winning across our product categories
Winning across our product categories Reported H1 2024 figures (including Stella Pack) Comparable H1 2024 figures (excluding Stella Pack)* NET SALES EBIT EBIT % NET SALES EBIT EBIT % y-o-y y-o-y y-o-y y-o-y y-o-y y-o-y Beauty, Skin € 44.3m € 9.4m 21.1% € 44.3m € 9.4m 21.1% & Sun Care + 36.9% + 130.3
Slide 16: Balanced performance across our geographies
Balanced performance across our geographies Reported H1 2024 figures (including Stella Pack) Comparable H1 2024 figures (excluding Stella Pack)* NET SALES EBIT EBIT% NET SALES EBIT EBIT% y-o-y y-o-y y-o-y y-o-y y-o-y y-o-y € 88.9m € 12.4m 13.9% € 88.9m € 12.4m 13.9% Greece + 454bps + 18.5% + 75.8% +
Slide 17: Strong balance sheet
Strong balance sheet ▪ Balance sheet provides firepower & flexibility to ▪ invest organically ▪ Stella Pack’s acquisition funded by ▪ support the transformation of the existing cash Group ▪ fuel M&A activity ▪ Secured facilities of c. €54m committed as a war-chest for further acquisitions ▪ Stable f
Slide 18: Enhancing shareholders value
Enhancing shareholders value EPS €0.3745 Dividend of €15.0m (+50% to PY) paid in per share May 2024 (+ 30.7%) €0.224381 per share Share buy-back program Dividend payout in place ratio 38.2% (€8.5m outflow for (vs 38.0% in the PY) treasury shares during H1 2024) Dividends paid since 2014 Buy-backs >
Slide 19: Delivering Strong Shareholder Value
Delivering Strong Shareholder Value 5-Year Plan
Slide 20: Disproportional growth on Beauty & Skin care
Disproportional growth on Beauty & Skin care CAGR Net Sales (€m) 2023 2024* 2025 2026 2027 2028 2023-2028 Own brands 349.6 454.3 481.7 509.0 537.7 568.7 10.2% Beauty & Skin Care 48.2 57.2 70.0 77.7 87.1 99.7 15.7% Personal Care 102.8 108.1 112.7 120.1 127.8 134.9 5.6% Home Care 198.7 288.9 299.1 311
Slide 21: Doubling the EBITDA Organically in the next 5 years
Doubling the EBITDA Organically in the next 5 years (€m) 2023 2024* 2025 2026 2027 2028 Net Sales 482.2 595.2 627.9 662.5 698.9 737.4 %YoY 23.5% 5.5% 5.5% 5.5% 5.5% Gross Margin 182.0 225.1 239.3 254.5 270.6 287.6 % on NS 37.8% 37.8% 38.1% 38.4% 38.7% 39.0% A&P 28.6 33.9 37.2 40.6 41.5 42.4 % on NS
Slide 22: Investing for our future - Capex
Investing for our future - Capex Capex 2024 2025 2026 2027 2028 Oinofyta DC* € 7.0m € 18.0m Digital* € 5.0m € 4.0m € 3.0m transformation Stella € 3.0m € 6.0m € 5.0m € 2.0m € 2.0m Rest of Group € 5.0m € 5.0m € 4.0m € 6.0m € 6.0m Total € 20.0m € 33.0m € 12.0m € 8.0m € 8.0m €81.0 million investment pla
Slide 23: A business with Strong Free Cash Flow generation
A business with Strong Free Cash Flow generation € million 2023 2024 2025 2026 2027 2028 EBITDA 61.6 80.2 90.3 100.5 110.3 120.2 Tax 9.6 10.2 11.5 13.3 14.9 16.5 Working capital change (7.2) 14.1 0.8 (0.6) 0.4 2.2 Capex 7.3 20.0 33.0 12.0 8.0 8.0 Estee Lauder Sale Receivable 20.6 20.6 FCF 51.9 35.9
Slide 24: Accelerating our ESG agenda
Accelerating our ESG agenda
Slide 25: Integrating ESG into our Business
Integrating ESG into our Business Engaging with our Double materiality Target setting stakeholders assessment by the end of 2024 already completed 25 Sarantis Group Investors Presentation
Slide 26: Investing in a more sustainable future
Investing in a more sustainable future Energy Consumption from Scope 1 GHG emissions Scope 2 GHG emissions Energy Intensity** Renewable Resources* (in tCO2e) (in tCO2e) market-based Period 2021-2023 Period 2021-2023 Period 2022-2023 Period 2021-2023 +65% -14% -7.4% -15.4% *Renewable energy sources u
Slide 27: Focusing on green growth and competitiveness
Focusing on green growth and competitiveness new refillable AVA Sanitas / FINO clean beauty flex&strong garbage 18% less plastic – more brand Clinea than 70 tons of plastic 100% recyclable bags capsule 100% recycled plastic reduction per year (2020-2023) Noxzema men roll-on: Bioten STR8 deo spray re
Slide 28: Raising Corporate Governance Standards
Raising Corporate Governance Standards New Board of Directors * Executive Directors ✓ 4 Executive Directors * Kyriakos Sarantis, Chairman of the Board ✓ 6 Non-Executive Directors Giannis Bouras, CEO ✓ 30% of the members are women Christos Varsos, Group CFO ✓ 4 Independent Non-Executive Directors Eva
Slide 29: Aligning management's with shareholders' interests
Aligning management’s with shareholders’ interests Long-term incentive scheme established: ✓ Running in three-year performance cycles with targets EBITDA margin, Operating Working Capital as % of Net Sales ✓ LTI grants free shares at the end of each three-year period (no dilution, treasury stock) ✓
Slide 30: Why Sarantis has a strong Investment Case
Why Sarantis has a strong Investment Case ▪ Sustainable organic growth engine 01 ▪ ▪ Leading presence in all geographies Strong brand portfolio in the right categories ▪ Strong supply chain footprint with continuous investment plan 2X EBITDA in 5 years ▪ 02 ▪ Consistent dividend ~ 38% payout in rece
Slide 31: Appendix
Appendix
Slide 32: Our brands
Our brands Beauty, Skin & Sun Care Personal Care 32 Sarantis Group Investors Presentation
Slide 33: Our brands – Home Care Solutions
Our brands – Home Care Solutions 33 Sarantis Group Investors Presentation
Slide 34: Strategic Partnerships – Mass Distribution
Strategic Partnerships – Mass Distribution 34 Sarantis Group Investors Presentation
Slide 35: Strategic Partnerships – Selective Distribution
Strategic Partnerships – Selective Distribution 35 Sarantis Group Investors Presentation
Slide 36: Recent Acquisitions
Recent Acquisitions 2014 2015 2015 2018 2018 2020 2024 Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition ✓ Cosmetics brand ✓ Hand-dishwashing ✓ Production of PL ✓ Cosmetics brand ✓ Leading player in the ✓ Cosmetics br
Slide 37: For further information on Sarantis Group
For further information on Sarantis Group please visit our website at https://sarantisgroup.com/ or contact our Investor Relations team: Eleni Moustakidou Investor Relations Manager emoustakidou@sarantisgroup.com +30 210 6173065